Insider trades
Galbraith Kenneth, Chairman of Zymeworks ZYME, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $3.3M. The latest trade was on 01/12.
Galbraith Kenneth
Chair & CEO
- Company
- Zymeworks ZYME
- First filing
- 23/01/06
- Trades
- 31 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$3.3M
- Last trade
- 01/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ZymeworksZYME | Open-market sale | 01/12 | 01/12 | 30,424 sh | $22.67 | $689,712.08 | −11.8% |
ZYME | Open-market sale | 01/05 | 01/05 | 54,343 sh2 trades | $25.10avg. | $1,364,009.3 | −21.9% |
ZymeworksZYME | Open-market sale | 25/12/22 | 25/12/22 | 47,528 sh | $27.02 | $1,284,206.56 | −26.3% |
ZYME | Open-market sale | 25/01/06 | 25/01/06 | 57,291 sh2 trades | $14.92avg. | $854,781.72 | −41.5% |
ZYME | Open-market sale | 24/01/05–24/01/08 | 24/01/08 | 23,904 sh2 trades | $10.79avg. | $257,830.02 | −50.1% |